Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Odyssey Health, Inc.ODYY · Entity 8618 | Director | June 28, 2024 | July 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Odyssey Health, Inc.
Report date June 28, 2024 · Filed July 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2034-06-27 | Direct | 300,000 |
Reported balance
After 2024-06-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-28 · Grant · Acquired 300,000 · Balance 300,000 F1: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2024 Filed Jul 16, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.10 Strike: $0.10 | $30,000.00 |
DisclosureSEC source: 0001683168-24-004903 · ownership.xml · derivative · entry 1 Casey Jerome H · CIK 0001794095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-06-27 F1 · shares: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025. F1 · derivative.underlying_shares: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025. F1 · balance_after: The options vest 60,000 immediately; 60,000 vest on July 31, 2024; 60,000 vest on October 31, 2024; 60,000 vest on January 31, 2025; and 60,000 vest on April 30, 2025. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.10 Strike: $0.10 | $25,000.00 |
DisclosureSEC source: 0001683168-24-000022 · ownership.xml · derivative · entry 1 Casey Jerome H · CIK 0001794095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-12-28 F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023 F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023 F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023 Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 17:15 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantRestricted Stock Unit (Right to Buy) · Derivative | 500,000 | $0.30 Strike: $0.30 | $150,000.00 |
DisclosureSEC source: 0001683168-23-000190 · ownership.xml · derivative · entry 1 Casey Jerome H · CIK 0001794095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: ODYY - Common Stock · 500,000 shares Expires not disclosed F1 · derivative.expiration_date: No expiration date Read SEC document |
| May 19, 2022 Filed Jun 8, 2022 17:16 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.30 Strike: $0.30 | $75,000.00 |
DisclosureSEC source: 0001683168-22-004238 · ownership.xml · derivative · entry 2 Casey Jerome H · CIK 0001794095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 250,000 shares Expires 2032-05-18 Read SEC document |
| May 19, 2022 Filed Jun 8, 2022 17:16 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.30 Strike: $0.30 | $75,000.00 |
DisclosureSEC source: 0001683168-22-004238 · ownership.xml · derivative · entry 1 Casey Jerome H · CIK 0001794095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 250,000 shares Expires 2032-05-18 Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 17:34 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantRestricted Stock Unit (Right to Buy) · Derivative | 500,000 | $0.45 Strike: $0.45 | $225,000.00 |
DisclosureSEC source: 0001683168-21-004317 · ownership.xml · derivative · entry 1 Casey Jerome H · CIK 0001794095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 500,000 shares Expires not disclosed F1 · derivative.exercise_date: The vesting of the RSU (Units) is as follows: 500,000 RSU vest equally over 12 months, subject to the Grantee's continuous service through the applicable vesting date. If not forfeited, vesting of the Units will be accelerated and will vest in full immediately upon the closing of a Corporate Transaction, provided that Grantee provides Continuous Service to the Company through the date such Corporate Transaction is closed. Vested Units will be settled by delivering to Grantee a number of shares equal to the number of vested Units on the earlier of the date on which the Grantee's Continuous Service ends, or the closing of a Corporate Transaction. F2 · derivative.expiration_date: No expiration. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.